)
)
RVL Pharmaceuticals PLC Investor Relations Material
Latest events
Q2 2023
RVL Pharmaceuticals PLC
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from RVL Pharmaceuticals PLC
Access all reports
RVL Pharmaceuticals PLC is a specialty pharmaceutical company that focuses on developing and commercializing products in the ocular and medical aesthetics sectors. Its main product, Upneeq (oxymetazoline hydrochloride ophthalmic solution, 0.1%), is FDA-approved for the treatment of acquired blepharoptosis, or low-lying eyelids, offering a non-surgical option for adults. The company serves underserved patient populations primarily in the United States and operates in several international markets. RVL Pharmaceuticals is headquartered in Bridgewater, New Jersey, and its shares are listed on the OTC Markets.
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
RVLP
Country
🇺🇸 United States